Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ACI’s Antiseptic Testing Continues Under Specter Of FDA Administrative Order

May 03 2021

• By Ryan Nelson

Building icon with inscription FDA and flag of The United States over abstract background. - Illustration

Related Content

ACI Has $10M Plan For Supporting Antibac Ingredients, If FDA Hasn’t Already Closed The Door

Oct 27 2016

FDA Rule Marks Consumer Antibacterial Soaps An Endangered Category

Sep 02 2016

FDA’s OTC Program Has Changed, But Antiseptic Sector Prepares For More Of The Same

Apr 20 2020

ACI Still Musing On ‘Two Islands Study’ For OTC Consumer Antiseptics While Ticking GRASE Data Boxes

Apr 28 2020

US OTC Monograph Reform's Early Results Could Be Label Orders From FDA, Wait And See For Industry

Apr 16 2020

At US FDA, Adding ‘Effective’ Staff For Overhauled OTC Monograph Program ‘Really Takes Time’

Sep 02 2020

Has COVID Changed US FDA’s Thinking About OTC Antiseptics?

May 03 2021

Additional Topics

United States FDA Regulation Ingredients Cosmetics OTC Drugs Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window